Introduced
2025.02
Kick-off IND-Enabling
Introduced
2023.09
In the portfolio of JLABS
Introduced
2021.4
1st patent granted
Introduced
2020.12
SBC003 showed neurorescuing
effects in a rd10 model for RP
Introduced
2019.11
SBC003 showed neuroprotective
effects in an NMU model for RP
Introduced
2018.11
SunRegen won the startup
competition in BioEurope
Introduced
2018.10
SunRegen is granted
SME Seal of Excellence
Introduced
2017.12
SunRegen project was one
of the IMAGINE IF!
Global Top 20 Finalists
Introduced
2017.8
BaseLaunch, a life science
accelerator in
Basel Region, selects
SunRegen into its portfolio
Introduced
2017.5
Swiss CTI granted
coaching support
service to SunRegen
Introduced
2017.2
SunRegen Healthcare AG
was founded to develop
SBC003 into a new drug
Introduced
2006.12
SBC003 neuroprotective,
neuro-rescuing, neurotrophic, and
axon-outgrowth effects were proven
by a series of in vitro
Prove-of-Concept tests
Introduced
2006.2
SBC003 was
discovered
